@phdthesis{oai:kindai.repo.nii.ac.jp:02000487,
 author = {山本, 真也 and Yamamoto, Shinya},
 month = {Mar},
 note = {主査：川畑篤史 教授　　学内授与番号：薬第189号
Shinya Yamamoto, Kazuhiko Matsuo, Daisuke Nagakubo, Shintaro Higashiyama, Keiji Nishiwaki, Naoki Oiso, Akira Kawada, Osamu Yoshie, Takashi Nakayama "A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment" Journal of Pharmacological Sciences, Volume 136, Issue 3, March 2018, Pages 165-171
https://doi.org/10.1016/j.jphs.2018.02.001  掲載
Shinya Yamamoto, Kazuhiko Matsuo, Sho Sakai, Itsuki Mishima, Yuta Hara, Naoki Oiso, Akira Kawada, Osamu Yoshie, Takashi Nakayama "P2X receptor agonist enhances tumor-specific CTL responses through CD70+ DC-mediated Th17 induction" International Immunology, Volume 33, Issue 1, January 2021, Pages 49–55
https://doi.org/10.1093/intimm/dxaa068  掲載},
 school = {近畿大学, Kindai University},
 title = {ヘルパーT細胞サブセットの機能を選択的に制御することによる新規ワクチンアジュバントに関する研究},
 year = {2023},
 yomi = {ヤマモト, シンヤ}
}